Cerebral organoids generated from DS iPSCs display pathological AD hallmarks including elevated amyloid-ß and hyperphosphorylated tau (Gonzalez et al., 2018; Zhao and Haddad, 2022; Campbell et al., 2023; Czerminski et al., 2023) (Table 1). Here, MAPT is linked to Alzheimer disease.